On September 4, 2012, the manufacturer issued a voluntary recall of one lot of Nimodipine 30 mg capsules marketed by Caraco Pharmaceutical Laboratories as a precautionary measure after a complaint from a customer who noticed that the capsule contents contained crystals. Although no adverse events have been reported, the manufacturer is concerned about the alteration of the drug’s bio-availability. How do you educate yourself about drug recalls?

For more information about the lot numbers, please visit the FDA.